메뉴 건너뛰기




Volumn 17, Issue 3, 2008, Pages 170-177

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial

(16)  Kjeldsen, Sverre E a,b   McInnes, Gordon T c   Mancia, Giuseppe d   Hua, Tsushung A e   Julius, Stevo a   Weber, Michael A f   Coca, Antonio g   Girerd, Xavier h   Jamerson, Kenneth a   Larochelle, Pierre i   MacDonald, Thomas j   Schmieder, Roland E k   Schork, M Anthony a   Viskoper, Reuven l   Widimsky, Jiri m   Zanchetti, Alberto n  


Author keywords

Amlodipine; Blood pressure; Diabetes; Hypertension; Prevention; Valsartan

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; VALSARTAN;

EID: 48549104957     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050802169644     Document Type: Article
Times cited : (12)

References (29)
  • 1
    • 0037035775 scopus 로고    scopus 로고
    • Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
    • Howard, B. V., Rodrigues, B. L. and Bennett, P. H. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: epidemiology. 105, pp. e132-e137.
    • (2002) , vol.105
    • Howard, B.V.1    Rodrigues, B.L.2    Bennett, P.H.3
  • 2
    • 0026081237 scopus 로고
    • The epidemiology of impaired glucose tolerance and hypertension
    • Kannel, W. B., Wilson, P. W. and Zhang, T. J. (1991) The epidemiology of impaired glucose tolerance and hypertension. 121, pp. 1268-1273.
    • (1991) , vol.121 , pp. 1268-1273
    • Kannel, W.B.1    Wilson, P.W.2    Zhang, T.J.3
  • 3
    • 12344282783 scopus 로고    scopus 로고
    • Global burden of hypertension: Analysis of worldwide data
    • Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K. and He, J. (2005) Global burden of hypertension: Analysis of worldwide data. 365, pp. 217-223.
    • (2005) , vol.365 , pp. 217-223
    • Kearney, P.M.1    Whelton, M.2    Reynolds, K.3    Muntner, P.4    Whelton, P.K.5    He, J.6
  • 4
    • 0035856920 scopus 로고    scopus 로고
    • Global and societal implications of the diabetic epidemic
    • Zimmet, P., Alberti, K. G. M. M. and Shaw, J. (2001) Global and societal implications of the diabetic epidemic. 414, pp. 782-787.
    • (2001) , vol.414 , pp. 782-787
    • Zimmet, P.1    Alberti, K.G.M.M.2    Shaw, J.3
  • 5
    • 0033034404 scopus 로고    scopus 로고
    • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
    • Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T. Niklason, A. et al. (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. 353, pp. 611-616.
    • (1999) , vol.353 , pp. 611-616
    • Hansson, L.1    Lindholm, L.H.2    Niskanen, L.3    Lanke, J.4    Hedner, T.5    Niklason, A.6
  • 6
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • The Heart Outcomes Prevention Evaluation Study Investigators
    • The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. 342, pp. 145-153.
    • (2000) , vol.342 , pp. 145-153
  • 7
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone. The Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone. The Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). 283, pp. 1967-1975.
    • (2000) , vol.283 , pp. 1967-1975
  • 8
    • 0034730027 scopus 로고    scopus 로고
    • Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study
    • Hansson, L., Hedner, T., Lund-Johansen, P., Kjeldsen, S. E., Lindholm, L. H. Syvertsen, J. O. et al. (2000) Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study. 356, pp. 359-365.
    • (2000) , vol.356 , pp. 359-365
    • Hansson, L.1    Hedner, T.2    Lund-Johansen, P.3    Kjeldsen, S.E.4    Lindholm, L.H.5    Syvertsen, J.O.6
  • 9
    • 0034729993 scopus 로고    scopus 로고
    • Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    • Brown, M., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T. and Ruilope, L. M. (2000) Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). 356, pp. 366-372.
    • (2000) , vol.356 , pp. 366-372
    • Brown, M.1    Palmer, C.R.2    Castaigne, A.3    de Leeuw, P.W.4    Mancia, G.5    Rosenthal, T.6    Ruilope, L.M.7
  • 10
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 288, pp. 2981-2997.
    • (2002) , vol.288 , pp. 2981-2997
  • 11
    • 3843080682 scopus 로고    scopus 로고
    • Old antihypertensives and new diabetes
    • Opie, L. H. and Schall, R. (2004) Old antihypertensives and new diabetes. 22, pp. 1453-1458.
    • (2004) , vol.22 , pp. 1453-1458
    • Opie, L.H.1    Schall, R.2
  • 12
    • 29244436688 scopus 로고    scopus 로고
    • New onset diabetes and antihypertensive drugs
    • Mancia, G., Grassi, G. and Zanchetti, A. (2006) New onset diabetes and antihypertensive drugs. 24, pp. 3-10.
    • (2006) , vol.24 , pp. 3-10
    • Mancia, G.1    Grassi, G.2    Zanchetti, A.3
  • 13
    • 0031690680 scopus 로고    scopus 로고
    • The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
    • for the VALUE Trial Group
    • Mann, J., Julius, S. and for the VALUE Trial Group (1998) The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design. 7, pp. 176-183.
    • (1998) , vol.7 , pp. 176-183
    • Mann, J.1    Julius, S.2
  • 14
    • 17844382949 scopus 로고    scopus 로고
    • Characteristics of 15314 hypertensive patients at high coronary risk. The VALUE Trial
    • Kjeldsen, S. E., Julius, S., Brunner, H. R., Hansson, L., Henis, M. Ekman, S. et al. (2001) Characteristics of 15314 hypertensive patients at high coronary risk. The VALUE Trial. 10, pp. 83-91.
    • (2001) , vol.10 , pp. 83-91
    • Kjeldsen, S.E.1    Julius, S.2    Brunner, H.R.3    Hansson, L.4    Henis, M.5    Ekman, S.6
  • 15
    • 10744226529 scopus 로고    scopus 로고
    • VALUE Trial: Long-term BP trends in 13,449 patients with hypertension and high cardiovascular risk
    • for the Value Trial
    • Julius, S., Kjeldsen, S. E., Brunner, H. R., Hansson, L., Platt, F., Ekman, S. for the Value Trial et al. (2003) VALUE Trial: Long-term BP trends in 13,449 patients with hypertension and high cardiovascular risk. 16, pp. 544-548.
    • (2003) , vol.16 , pp. 544-548
    • Julius, S.1    Kjeldsen, S.E.2    Brunner, H.R.3    Hansson, L.4    Platt, F.5    Ekman, S.6
  • 16
    • 2942635317 scopus 로고    scopus 로고
    • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
    • for the VALUE trial group
    • Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L. for the VALUE trial group et al. (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. 363, pp. 2022-2031.
    • (2004) , vol.363 , pp. 2022-2031
    • Julius, S.1    Kjeldsen, S.E.2    Weber, M.A.3    Brunner, H.R.4    Ekman, S.5    Hansson, L.6
  • 17
    • 2942695964 scopus 로고    scopus 로고
    • Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
    • for the VALUE trial group
    • Weber, M. A., Julius, S., Kjeldsen, S. E., Brunner, H. R., Ekman, S., Hansson, L. for the VALUE trial group et al. (2004) Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. 363, pp. 1047-1049.
    • (2004) , vol.363 , pp. 1047-1049
    • Weber, M.A.1    Julius, S.2    Kjeldsen, S.E.3    Brunner, H.R.4    Ekman, S.5    Hansson, L.6
  • 18
    • 33745464829 scopus 로고    scopus 로고
    • Effects of valsartan compared to amlodipine on preventing type 2 diabetes mellitus in high-risk hypertensives patients: The VALUE trial
    • Kjeldsen, S. E., Julius, S., Mancia, G., McInnes, G. T., Hua, T. Weber, M. A. et al. (2006) Effects of valsartan compared to amlodipine on preventing type 2 diabetes mellitus in high-risk hypertensives patients: The VALUE trial. 24, pp. 1405-1412.
    • (2006) , vol.24 , pp. 1405-1412
    • Kjeldsen, S.E.1    Julius, S.2    Mancia, G.3    McInnes, G.T.4    Hua, T.5    Weber, M.A.6
  • 19
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G. de Faire, U. et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. 359, pp. 995-1003.
    • (2002) , vol.359 , pp. 995-1003
    • Dahlof, B.1    Devereux, R.B.2    Kjeldsen, S.E.3    Julius, S.4    Beevers, G.5    de Faire, U.6
  • 20
    • 18544376399 scopus 로고    scopus 로고
    • Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
    • Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Hecht Olsen, M., Wachtell, K. Dahlof, B. et al. (2002) Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. 20, pp. 1879-1886.
    • (2002) , vol.20 , pp. 1879-1886
    • Lindholm, L.H.1    Ibsen, H.2    Borch-Johnsen, K.3    Hecht Olsen, M.4    Wachtell, K.5    Dahlof, B.6
  • 21
    • 48549087845 scopus 로고    scopus 로고
    • WHO. Department of Non-Communicable Disease Surveillance WHO, Geneva
    • WHO. Department of Non-Communicable Disease Surveillance (1999) pp. 1-59. WHO, Geneva
    • (1999) , pp. 1-59
  • 22
    • 48549100521 scopus 로고    scopus 로고
    • Predictors of diabetes in high risk hypertensive patients in the Value Trial
    • Aksnes, T. A., Rostrup, M., Kjeldsen, S. E., Storset, Ø., Hua, A. and Julius, S. (2008) Predictors of diabetes in high risk hypertensive patients in the Value Trial.
    • (2008)
    • Aksnes, T.A.1    Rostrup, M.2    Kjeldsen, S.E.3    Storset, Ø.4    Hua, A.5    Julius, S.6
  • 23
    • 0037534905 scopus 로고    scopus 로고
    • The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial
    • for the SCOPE Study Group
    • Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B. for the SCOPE Study Group et al. (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. 21, pp. 875-886.
    • (2003) , vol.21 , pp. 875-886
    • Lithell, H.1    Hansson, L.2    Skoog, I.3    Elmfeldt, D.4    Hofman, A.5    Olofsson, B.6
  • 25
    • 0025997702 scopus 로고
    • The hemodynamic link between insulin resistance and hypertension
    • Julius, S., Gudbrandsson, T., Jamerson, K. A., Tariq, S. S. and Andersson, O. (1991) The hemodynamic link between insulin resistance and hypertension. 9, pp. 983-986.
    • (1991) , vol.9 , pp. 983-986
    • Julius, S.1    Gudbrandsson, T.2    Jamerson, K.A.3    Tariq, S.S.4    Andersson, O.5
  • 26
    • 33750314218 scopus 로고    scopus 로고
    • Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
    • Aksnes, T. A., Reims, H., Gupta, S., Moan, A., Os, I. and Kjeldsen, S. E. (2006) Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. 20, pp. 860-866.
    • (2006) , vol.20 , pp. 860-866
    • Aksnes, T.A.1    Reims, H.2    Gupta, S.3    Moan, A.4    Os, I.5    Kjeldsen, S.E.6
  • 27
    • 0031911742 scopus 로고    scopus 로고
    • Angiotensin II and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats
    • Carlsson, P-O., Berne, C. and Jansson, L. (1998) Angiotensin II and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats. 41, pp. 127-133.
    • (1998) , vol.41 , pp. 127-133
    • Carlsson, P.-O.1    Berne, C.2    Jansson, L.3
  • 28
    • 0036840307 scopus 로고    scopus 로고
    • Angiotensin blockade prevents type 2 diabetes by formation of fat cells
    • Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S. and Luft, F. C. (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. 40, pp. 609-611.
    • (2002) , vol.40 , pp. 609-611
    • Sharma, A.M.1    Janke, J.2    Gorzelniak, K.3    Engeli, S.4    Luft, F.C.5
  • 29
    • 33846294746 scopus 로고    scopus 로고
    • Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis
    • Elliott, W. J. and Meyer, P. M. (2007) Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. 369, pp. 201-207.
    • (2007) , vol.369 , pp. 201-207
    • Elliott, W.J.1    Meyer, P.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.